Sun Pharma, Lupin Agree To Drop Eye Pain Patent Dispute

By Tiffany Hu · February 8, 2022, 7:33 PM EST

Sun Pharma on Tuesday agreed to drop a patent lawsuit against rival Lupin Pharmaceuticals over a branded treatment to prevent pain from eye surgery, while getting a New Jersey federal judge...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

SUN PHARMACEUTICAL INDUSTRIES LTD. et al v. LUPIN LIMITED et al

Case Number

Court

New Jersey

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

February 15, 2018

Recent Articles By Tiffany

June 13, 2023
Spinal Device Co. Gets $6M Bond Cut In Trade Secrets Suit
March 27, 2023
Wholesaler To Pay $33.4M In Abbott Labs Test Strips TM Row
February 16, 2023
TTAB Won't Let Diagnostic Co. Register 'NF-Light' TM
February 07, 2023
Instacart Co-Founder Hit With TRO In Trade Secrets Fight
January 20, 2023
Brand Battles: Uber Tries To Drive Out 'Uberhorny' Dating TM
January 04, 2023
TTAB Rejects Health Care Co.'s TM As Descriptive
March 21, 2022
Justices Skip $420M Secrets Suit, 'Candy Colors' Fight & More
March 09, 2022
Alvotech, AbbVie Deal Allows For Humira Biosimilar In 2023
February 25, 2022
Brand Battles: BetterUp Takes Aim At 'BetterHelp' Trademark
February 07, 2022
Generics Co. Accuses Ex-Exec Of Swiping Trade Secrets